HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [Yahoo! Finance]
Agenus Inc. (AGEN)
Last agenus inc. earnings: 3/12 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
agenusbio.com/investors
Company Research
Source: Yahoo! Finance
disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. [2] Arexvy is 94.6% efficacious in preventing LRTD caused by RSV in older adults aged 60 years or over and with at least one underlying medical condition, such as cardiorespiratory and endocrine-metabolic (including asthma, COPD, diabetes, chronic heart failure, among others). [8] Arexvy is the first RSV vaccine approved in Singapore SINGAPORE May 16, 2024 /PRNewswire/ -- Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. [2] The first respiratory syncytial virus (RSV) vaccine in the world [1] and the first RSV vaccine approved in the country, Arexvy (recombinant, AS01E adjuvanted) further strengthens the company's portfolio of vaccines aimed to protect older adults in Singapore from a
Show less
Read more
Impact Snapshot
Event Time:
AGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGEN alerts
High impacting Agenus Inc. news events
Weekly update
A roundup of the hottest topics
AGEN
News
- Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) ShareholdersAccesswire
- Agenus Inc. Class Action: Levi & Korsinsky Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024 - AGENAccesswire
- AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!GlobeNewswire
- Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Agenus Inc. (AGEN) ShareholdersAccesswire
- The Schall Law Firm Encourages Investors To Take Part In A Securities Fraud Case Against Agenus Inc. Accesswire
AGEN
Earnings
- 8/8/24 - Miss
AGEN
Sec Filings
- 10/22/24 - Form SC
- 10/21/24 - Form 4
- 10/7/24 - Form 4
- AGEN's page on the SEC website